FDA Webview
X

Free FDA Notices

OMB OKs Info on Non-Rx Drug Adverse Event Reporting

02/03/2016

Federal Register Notice: FDA’s collection of information entitled “Guidance for Industry on Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application,” has been approved by the Office of Management and Budget under the Paperwork Reduction Act of 1995. To view this notice, click here.

LATEST NEWS